Age-related progression of arterial stiffness and its elevated positive association with blood pressure in healthy people

Atherosclerosis

Volumn 238, Issue 1, 2015, Pages 147-152

  Wen, Wen ^a   Luo, Rong ^b   Tang, Xiaojing ^a   Tang, Lan ^b   Huang, Hunter X ^a   Wen, Xiaoyan ^a   Hu, Shan ^a   Peng, Bin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Age; Arterial stiffness; Blood pressure; Cardio ankle vascular index (CAVI); Growth curve

Indexed keywords

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CARDIO ANKLE VASCULAR INDEX; CLINICAL ASSESSMENT TOOL; DISEASE COURSE; FEMALE; GROUPS BY AGE; GROWTH CURVE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ANKLE; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE MEASUREMENT; HEART; HYPERTENSION; MIDDLE AGED; NORMAL HUMAN; PATHOPHYSIOLOGY; STATISTICAL MODEL; VASCULARIZATION; YOUNG ADULT;

BIOLOGICAL MARKER;

ADULT; AGE FACTORS; AGED; ANKLE; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DISEASE PROGRESSION; FEMALE; HEALTHY VOLUNTEERS; HEART; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84914141795     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.089     Document Type: Article

References (49)

1. Cecelja M., Chowienczyk P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc. Dis. 2012, 1(4):1-11.
2. Lee H.Y., Oh B.H. Aging and arterial stiffness. Circ. J. 2010, 74(11):2257-2262.
3. Avolio A.P., Chen S.G., Wang R.P., et al. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983, 68(1):50-58.
4. Avolio A.P., Deng F.Q., Li W.Q., et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985, 71(2):202-210.
5. Hirasada K., Niimura H., Kubozono T., et al. Values of cardio-ankle vascular index (CAVI) between Amami islands and Kagoshima mainland among health checkup examinees. J.Atheroscler. Thromb. 2012, 19(1):69-80.
6. McEniery C.M., Hall I.R., Qasem A., et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J.Am. Coll. Cardiol. 2005, 46(9):1753-1760.
7. Choi S.Y., Oh B.H., Bae P.J., et al. Age-associated increase in arterial stiffness measured according to the cardio-ankle vascular index without blood pressure changes in healthy adults. J.Atheroscler. Thromb. 2013, 20(12):911-923.
8. Shirai K., Utino J., Otsuka K., et al. Anovel blood pressure-independent arterial wall stiffness parameter: cardio-ankle vascular index (CAVI). J.Atheroscler. Thromb. 2006, 13(2):101.
9. Takaki A., Ogawa H., Wakeyama T., et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ. J. off. J. Jpn. Circ. Soc. 2007, 71(11):1710-1714.
10. Shirai K., Song M., Suzuki J., et al. Contradictory effects of β1-and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)-CAVI independent of blood pressure. J.Atheroscler. Thromb. 2011, 18(1):49.
11. Kubozono T., Miyata M., Ueyama K., et al. Clinical significance and reproducibility of new arterial distensibility index. Circ. J. off. J. Jpn. Circ. Soc. 2007, 71(1):89-94.
12. Yambe T., Yoshizawa M., Saijo Y., et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed. Pharmacother. 2004, 58:S95-S98.
13. Feigelson H.S., Criqui M.H., Fronek A., et al. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am. J. Epidemiol. 1994, 140(6):526-534.
14. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA J. Am. Med. Assoc. 2008, 300(2):197. Ankle Brachial Index Collaboration.
15. Semba R.D., Najjar S.S., Sun K., et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am. J. Hypertens. 2009 Jan, 22(1):74-79.
16. Atkinson J. Age-related medial elastocalcinosis in arteries: mech-anisms, animalmodels, and physiological consequences. J.Appl. Physiol. 2008, 105:1643-1651.
17. Csiszar A., Wang M., Lakatta E.G., et al. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J.Appl. Physiol. 2008, 105:1333-1341.
18. Zhou X., Bohlen H.G., Unthank J.L., et al. Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by NAD(P)H oxidase-derived peroxide. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H2227-H2233.
19. Intengan H.D., Schiffrin E.L. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000, 36:312-318.
20. Qiu H., Zhu Y., Sun Z., et al. Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ. Res. 2010, 107:615-619.
21. Scuteri A., Cunha P.G., Rosei E.A., et al. Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. Atherosclerosis 2014, 233(2):654-660.
22. Shimizu Y., Nakazato M., Sekita T., et al. Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: the Nagasaki Islands Study. Atherosclerosis 2013 Jun, 228(2):491-495.
23. Zebekakis P.E., Nawrot T., Thijs L., et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J.Hypertens. 2005, 23(10):1839-1846.
24. Kannel W.B., Hjortland M.C., Mcnamara P.M., et al. Menopause and risk of cardiovascular disease the Framingham study. Ann. Intern. Med. 1976, 85(4):447-452.
25. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am. J. Cardiol. 2002, 89(12):12-17.
26. Gebara O.C.E., Mittleman M.A., Sutherland P., et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995, 91(7):1952-1958.
27. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N.Engl. J. Med. 1991, 325(11):756-762.
28. Samaan S.A., Crawford M.H. Estrogen and cardiovascular function after menopause. J.Am. Coll. Cardiol. 1995, 26(6):1403-1410.
29. Dubey R.K., Tyurina Y.Y., Tyurin V.A., et al. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ. Res. 1999, 84(2):229-239.
30. Vaziri S.M., Evans J.C., Larson M.G., et al. The impact of female hormone usage on the lipid profile: the Framingham offspring study. Arch. Intern Med. 1993, 153(19):2200-2206.
31. Tikkanen M.J., Nikkilä E.A., Kuusi T., et al. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J.Clin. Endocrinol. Metab. 1982, 54(6):1113-1117.
32. World Heart Federation World Congress of Cardiology Scientific Sessions 2008, http://www.world-heart-federation.org/press/releases/detail/article/stress-at-work-increases-the-progression-of-arteriosclerosis/.
33. Heliovaara M., Karvonen M.J., Vilhunen R., et al. Smoking, carbon monoxide, and atherosclerotic diseases. Br. Med. J. 1978, 1(6108):268-270.
34. Hughson W.G., Mann J.I., Garrod A., Garrod A. Intermittent claudication: prevalence and risk factors. Br. Med. J. 1978, 1(6124):1379-1381.
35. Doll R., Grey R., Hafner B., Peto R. Mortality in relationto smoking: 20 years' observation on female British doctors. Br. Med. J. 1980, 280(6219):967-971.
36. Price J.F., Mowbray P.I., Lee A.J., et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary arterial disease. Eur. Heart J. 1999, 20(5):344-353.
37. Patel R., Unisa S. Construction of national standards of growth curves of height and weight for children using cross-sectional data. Indian J. Public Health 2014, 58(2):92-99.
38. Czechowicz J.A., Chang K.W. Analysis of growth curves in children after adenotonsillectomy. JAMA Otolaryngol. Head. Neck Surg. 2014, 140(6):491-496.
39. Pachon V. Anew approach to sphygmomanometry. Presse Med. 1913, 12:229-331.
40. Pickering G.W. High Blood Pressure 1955, Grune and Stratton, New York, NY.
41. Kannel W.B., Gordon T., Schwartz M.J. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am. J. Cardiol. 1971, 27(4):335-346.
42. Stamler J., Neaton J.D., Wentworth D.N. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989, 13(5 Suppl.l):I2.
43. Bramwell J.C., Hill A.V. Velocity of transmission of the pulse-wave: and elasticity of arteries. Lancet 1922, 199(5149):891-892.
44. Blacher J., Staessen J.A., Girerd X., et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 2000, 160(8):1085-1089.
45. Cecelja M., Jiang B., McNeill K., et al. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions a twin study. J.Am. Coll. Cardiol. 2009, 54(8):695-703.
46. Sesso H.D., Stampfer M.J., Rosner B., et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000, 36(5):801-807.
47. Steppan J., Barodka V., Berkowitz D.E., et al. Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol. Res. Pract. 2011, 2011:263585.
48. Franklin S.S. Hypertension in older people: part 1. J.Clin. Hypertens. (Greenwich) 2006 Jun, 8(6):444-449.
49. Franklin S.S. Arterial stiffness and diastolic blood pressure: what is the connection?. Artery Res. 2006, s1-s6.